Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
life sciences
major depressive disorder
3
×
national blog main
national top stories
new york blog main
new york top stories
3
×
blackstone group
boston
david goldstein
depression
epilepsy
essential tremor
fda
investing
kiran reddy
perimenopausal depression
praxis precision medicines
san francisco blog main
san francisco top stories
steven petrou
aligos therapeutics
antisense oligonucleotide
baker brothers life sciences
benzodiazepine
benzodiazepines
biogen
biotech ipos
blackstone life sciences
blepharitis
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
cancer vaccine
cavion
What
biotechs
drugs
medicines
new
praxis
precision
research
aims
backed
cause
central
ceo
club
cns
companies
continued
crop
disorder
emerged
epilepsy
exceeded
firms
genes
genetic
group
haul
ipo
ipos
joined
kept
latest
leads
life
links
marcio
met
million
momentum
mutations
nasdaq
Language
unset
Current search:
" new york top stories "
×
" major depressive disorder "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M